Daratumumab-based three drug regimens for high-risk multiple myeloma: A meta-analysis.

Arafat Ali Farooqui,Muhammad Junaid Tariq,Shaha Nabeel,Aqsa Ashraf,Zahoor Ahmed,Muhammad Salman Faisal,Mohammad Ammad Ud Din,Zartashia Shahab,Alireza Setarehaseman,Faiz Anwer

Daratumumab-based three drug regimens for high-risk multiple myeloma: A meta-analysis.

2020

Arafat Ali Farooqui
Muhammad Junaid Tariq
Shaha Nabeel
Aqsa Ashraf
Zahoor Ahmed
Muhammad Salman Faisal
Mohammad Ammad Ud Din
Zartashia Shahab
Alireza Setarehaseman
Faiz Anwer

e20549Background: Efficacy of daratumumab (D) based regimens in high risk multiple myeloma (MM) (i.e, ISS stage II/III and t(4;14) or (del17p)) has not been thoroughly investigated. The aim of this...

Keywords:

Physical therapy
Oncology
Multiple myeloma
Meta-analysis
Internal medicine
Drug
Daratumumab
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations